AbbVie Pe Ratio from 2010 to 2025

ABBV Stock  USD 192.97  1.22  0.64%   
AbbVie PE Ratio yearly trend continues to be fairly stable with very little volatility. PE Ratio is likely to outpace its year average in 2025. During the period from 2010 to 2025, AbbVie PE Ratio regression line of quarterly data had mean square error of  189.99 and geometric mean of  25.29. View All Fundamentals
 
PE Ratio  
First Reported
2010-12-31
Previous Quarter
50.71
Current Value
53.24
Quarterly Volatility
16.66368737
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.5 B, Interest Expense of 2.7 B or Selling General Administrative of 7.8 B, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0289 or PTB Ratio of 17.2. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Pe Ratio Growth Pattern

Below is the plot of the Pe Ratio of AbbVie Inc over the last few years. It is AbbVie's PE Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
Pe Ratio10 Years Trend
Slightly volatile
   Pe Ratio   
       Timeline  

AbbVie Pe Ratio Regression Statistics

Arithmetic Mean29.28
Geometric Mean25.29
Coefficient Of Variation56.92
Mean Deviation13.93
Median24.18
Standard Deviation16.66
Sample Variance277.68
Range48.6246
R-Value0.60
Mean Square Error189.99
R-Squared0.36
Significance0.01
Slope2.10
Total Sum of Squares4,165

AbbVie Pe Ratio History

2025 53.24
2024 50.71
2023 56.34
2022 24.18
2021 20.76
2020 38.7
2019 16.64

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Pe Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
PE Ratio 50.71  53.24 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.